RAPT Therapeutics's market cap is currently $166.33M. The company's EPS TTM is $-2.78; its P/E ratio is ―; RAPT Therapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 1.53M	$ 3.81M	$ 5.04M	$ 0.00
Gross Profit	$ -3.55M	$ -1.28M	$ 2.82M	$ 5.04M	$ -1.33M
Operating Income	$ -127.06M	$ -85.80M	$ -69.21M	$ -53.21M	$ -43.63M
EBITDA	$ -125.85M	$ -84.75M	$ -68.21M	$ -52.09M	$ -42.30M
Net Income	$ -116.80M	$ -81.88M	$ -68.21M	$ -52.89M	$ -43.00M
Balance Sheet
Cash & Short-Term Investments	$ 158.86M	$ 249.07M	$ 189.65M	$ 111.51M	$ 77.38M
Total Assets	$ 173.33M	$ 266.21M	$ 198.64M	$ 118.97M	$ 84.60M
Total Debt	$ 6.91M	$ 8.99M	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -40.57M	$ -29.96M	$ -24.03M	$ -24.92M	$ -77.38M
Total Liabilities	$ 26.29M	$ 21.04M	$ 12.26M	$ 14.79M	$ 11.48M
Stockholders' Equity	$ 147.03M	$ 245.17M	$ 186.38M	$ 104.18M	$ 73.12M
Cash Flow
Free Cash Flow	$ -98.17M	$ -71.62M	$ -61.78M	$ -40.89M	$ -36.36M
Operating Cash Flow	$ -97.05M	$ -70.77M	$ -61.03M	$ -40.49M	$ -35.47M
Investing Cash Flow	$ 104.13M	$ -45.49M	$ -81.35M	$ -87.44M	$ -843.00K
Financing Cash Flow	$ 1.45M	$ 131.18M	$ 141.48M	$ 75.46M	$ 49.90M

Currency in USD

RAPT Therapeutics Earnings and Revenue History

Income Statement >

RAPT Therapeutics Debt to Assets

Balance Sheet >

RAPT Therapeutics Cash Flow

Cash Flow >

RAPT Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing